» Articles » PMID: 32150249

Cd9 Protects Photoreceptors from Injury and Potentiates Edn2 Expression

Overview
Specialty Ophthalmology
Date 2020 Mar 10
PMID 32150249
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Cd9 is a tetraspanin membrane protein that plays various roles in tissue development and disease pathogenesis, especially in cancer, but the expression patterns and function of Cd9 in retinal development and disease are not well understood. We asked its roles during retinal photoreceptor degeneration by using CD9-knockout mice.

Methods: Cd9 knockout mice and rd1 mice were used to examine roles of Cd9 for progression of photoreceptor degeneration. Reverse transcription-polymerase chain reaction and immunohistochemistry were mainly used as analytical methods.

Results: Cd9 transcripts were only weakly expressed in retina at embryonic day 14, but its expression level subsequently increased and peaked at around postnatal day 12. In 6-week-old female mice derived retina, mRNA expression decreased slightly but was maintained at a significant level. Published RNA-sequencing data and immunohistochemistry indicated that Cd9 was expressed abundantly in Müller glia and weakly in other retinal neurons. Notably, when photoreceptors were damaged, Cd9 expression was increased in rod photoreceptors and decreased in Müller glia. Cd9 knockout mice retinas developed normally; however, once the retina suffered damage, degeneration of photoreceptors was more severe in Cd9 knockout retinas than control retinas. Induction of Edn2, which is known to protect against photoreceptor damage, was severely hampered. In addition, induction of Socs3, which is downstream of gp130 (Il6st), was weaker in Cd9 knockout retinas.

Conclusions: Taken together, these findings indicate that, although Cd9 was dispensable for normal gross morphological development, it protected rod photoreceptors and enhanced Edn2 expression, possibly through modulation of gp130 signaling.

Citing Articles

CD9 protects the sperm from cytotoxic factors in the epididymis as extracellular components.

Kang W, Sugiyama K, Katano D, Horiike S, Morimoto H, Sato B MicroPubl Biol. 2023; 2023.

PMID: 37799198 PMC: 10550374. DOI: 10.17912/micropub.biology.000950.


Release of VAMP5-positive extracellular vesicles by retinal Müller glia in vivo.

Demais V, Pohl A, Wunderlich K, Pfaller A, Kaplan L, Barthelemy A J Extracell Vesicles. 2022; 11(9):e12254.

PMID: 36043482 PMC: 9428896. DOI: 10.1002/jev2.12254.


CD82 palmitoylation site mutations at Cys5+Cys74 affect EGFR internalization and metabolism through recycling pathway.

Bu J, Zhong W, Li M, He S, Zhang M, Zhang Y Acta Biochim Biophys Sin (Shanghai). 2022; 54(3):400-408.

PMID: 35538033 PMC: 9828285. DOI: 10.3724/abbs.2022011.


Mapping membrane lipids in the developing and adult mouse retina under physiological and pathological conditions using mass spectrometry.

Hamano F, Kuribayashi H, Iwagawa T, Tsuhako A, Nagata K, Sagara H J Biol Chem. 2021; 296:100303.

PMID: 33465374 PMC: 7949107. DOI: 10.1016/j.jbc.2021.100303.

References
1.
Terada N, Baracskay K, Kinter M, Melrose S, Brophy P, Boucheix C . The tetraspanin protein, CD9, is expressed by progenitor cells committed to oligodendrogenesis and is linked to beta1 integrin, CD81, and Tspan-2. Glia. 2002; 40(3):350-9. DOI: 10.1002/glia.10134. View

2.
Wright M, Tomlinson M . The ins and outs of the transmembrane 4 superfamily. Immunol Today. 1994; 15(12):588-94. DOI: 10.1016/0167-5699(94)90222-4. View

3.
Patel C, Narayanan S, Zhang W, Xu Z, Sukumari-Ramesh S, Dhandapani K . Activation of the endothelin system mediates pathological angiogenesis during ischemic retinopathy. Am J Pathol. 2014; 184(11):3040-51. PMC: 4215027. DOI: 10.1016/j.ajpath.2014.07.012. View

4.
Podergajs N, Motaln H, Rajcevic U, Verbovsek U, Korsic M, Obad N . Transmembrane protein CD9 is glioblastoma biomarker, relevant for maintenance of glioblastoma stem cells. Oncotarget. 2015; 7(1):593-609. PMC: 4808020. DOI: 10.18632/oncotarget.5477. View

5.
Miyake M, Nakano K, Itoi S, Koh T, Taki T . Motility-related protein-1 (MRP-1/CD9) reduction as a factor of poor prognosis in breast cancer. Cancer Res. 1996; 56(6):1244-9. View